Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
基本信息
- 批准号:10328259
- 负责人:
- 金额:$ 41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-21 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdaptive Immune SystemAddressAdultAnimal ModelB-LymphocytesBacterial InfectionsBiochemicalBiochemistryBiologicalBiological ProcessCell Differentiation processCell LineageCell MaturationCellsChIP-seqChronicCommunicable DiseasesDangerousnessDataDevelopmentDevelopmental GeneEnterobacteria phage P1 Cre recombinaseEnvironmentEvaluationEventExposure toFamilyFunctional disorderGatekeepingGene ExpressionGene Expression RegulationGene SilencingGenesGenetic TranscriptionGleanGoalsGram-Negative Bacterial InfectionsHematopoieticHomeoboxHomeodomain ProteinsHumanHuman BiologyIL8 geneImmuneImmune systemImmunologicsImmunologyIn VitroInfectionInflammationInflammatoryInflammatory ResponseKnockout MiceLinkLoxP-flanked alleleLymphoidMammalsMediatingModelingModernizationMolecularMorbidity - disease rateMusNF-kappa BNFKB Signaling PathwayOrganOrganismOrganogenesisOsteoclastsPathogenicityPathway interactionsPatternPhysiologicalPlayPluripotent Stem CellsProteinsRegulationRegulatory PathwayRepressor ProteinsResolutionRoleShort Interspersed Nucleotide ElementsSignal PathwaySignal TransductionSiteStressSystemTNF geneTestingTherapeutic InterventionTissuesTransgenic MiceWorkcell typechemokinechronic inflammatory diseasecombatcytokinedesigngene functiongene networkgenetic corepressorgenome-widehuman diseaseimmune activationimmune system functionin vivoinhibitorinnovationinsightmicrobialmouse modelnew therapeutic targetnovelnovel therapeuticspathogenpathogenic bacteriapathogenic microbepersistent bacterial infectionprogramspromoterprotein activationprotein expressionprotein functionreconstitutionrecruitresponsetissue injurytranscription factortranscriptome sequencing
项目摘要
Project Summary
The present study focuses on our discovery that developmentally silenced SIX-family transcription
factors are reactivated by TNF-family cytokines and potently suppress gene expression programs
induced by non-canonical NF-kB. By first characterizing the human cytokines and pathogen
associated molecular patterns (PAMPs) that induce Six1 and Six2 protein expression and by then
investigating the molecular components required for their reactivation (Aim 1), these studies will
reveal a new pathway for non-canonical NF-kB regulation in the mammalian immune system. Second,
we will determine how Six-proteins inhibit inflammatory gene expression programs through promoter
proximal mechanisms (Aim 2). Physiological significance of inflammatory resolution by Six-proteins
while be investigated in mammalian model organisms using three complementary mouse models of
Six1 protein function (Aim 3). Insights gleaned from these studies will explain how non-canonical NF-
kB is regulated at gene promoters and will also reveal co-repressor complexes that play important
roles in the inflammatory response to microbial pathogens. Developing new drugs that interfere with
the ability of SIX proteins to regulate non-canonical NF-kB during microbial infection would be an
innovative approach to combat human disease associated with NF-kB signaling dysfunction including
chronic inflammation. Therefore, by revealing molecular details of SIX-protein function in the
mammalian immune system, from biochemistry to mouse models of infection, we will uncover sites of
potential weakness that may be exploited for therapeutic intervention. Importantly, these studies will
also provide new insights into the pathogenic mechanisms of an important infectious disease-causing
agent and also into the biology of the human inflammatory response.
项目摘要
本研究的重点是我们发现,该发现在发育中沉默了六户转录
TNF家庭细胞因子重新激活了因素,并有效抑制基因表达程序
由非典型的NF-KB诱导。首先表征人类细胞因子和病原体
相关的分子模式(PAMP),诱导SIX1和SIX2蛋白表达,然后
研究其重新激活所需的分子成分(AIM 1),这些研究将
揭示了哺乳动物免疫系统中非典型NF-KB调节的新途径。第二,
我们将确定六蛋白如何通过启动子抑制炎症基因表达程序
近端机制(AIM 2)。六蛋白的炎症分辨率的生理意义
虽然可以使用三种互补小鼠模型在哺乳动物模型生物体中进行研究
SIX1蛋白功能(AIM 3)。从这些研究中收集的见解将解释非规范的NF-如何
KB受到基因启动子的调节
在对微生物病原体的炎症反应中的作用。开发出干扰的新药
六种蛋白在微生物感染期间调节非典型NF-KB的能力将是一种
与NF-KB信号传导功能障碍相关的人类疾病的创新方法包括
慢性炎症。因此,通过揭示六蛋白功能的分子细节
哺乳动物免疫系统,从生物化学到小鼠感染模型,我们将发现
可以利用治疗干预的潜在弱点。重要的是,这些研究将
还提供有关重要感染性疾病的致病机制的新见解
代理以及人类炎症反应的生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neal Mathew Alto其他文献
<em>Shigella</em> Puts the Brakes on the Host Cell Cycle
- DOI:
10.1016/j.chom.2007.08.003 - 发表时间:
2007-09-13 - 期刊:
- 影响因子:
- 作者:
Neal Mathew Alto - 通讯作者:
Neal Mathew Alto
Neal Mathew Alto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neal Mathew Alto', 18)}}的其他基金
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10112827 - 财政年份:2020
- 资助金额:
$ 41万 - 项目类别:
Resolution of Inflammation by the SIX-family Transcription Factors
通过六家族转录因子解决炎症
- 批准号:
10553188 - 财政年份:2020
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8235694 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8788709 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8415960 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function
真核信号酶的细菌调节:结构和功能
- 批准号:
8603244 - 财政年份:2012
- 资助金额:
$ 41万 - 项目类别:
Type III effector regulation of host GTPase signaling
宿主 GTPase 信号转导的 III 型效应器调节
- 批准号:
8503581 - 财政年份:2009
- 资助金额:
$ 41万 - 项目类别:
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
The developmental pathway of fetal-derived B cells
胎儿来源的 B 细胞的发育途径
- 批准号:
10735381 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别:
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 41万 - 项目类别: